Key facts
- This page summarizes Wendy Carruthers's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 04 Dec 2024, 16:13.
Wendy Carruthers - 02 Dec 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)
- Reporting relationship
- EVP, Human Resources
- Issuer ticker
- BSX
- Reported as of
- 02 Dec 2024
- Net transaction value
- -$551,611
- SEC form
- 4
- Accepted by SEC
- 04 Dec 2024, 16:13:38 UTC
- Prior SEC filing
- 04 Nov 2024
- Next SEC filing
- 12 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Susan Thompson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Wendy Carruthers filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 04 Dec 2024.
Change
- Previous filing in this sequence was filed on 04 Nov 2024.
- Current net transaction value: -$551,611.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BSX
transaction
Common Stock
Options Exercise
- Transaction value
- $52,919
- Shares
- +3,066
- Change %
- +9.6%
- Price
- $17.26
- Shares after
- 35,094
- Date
- 02 Dec 2024
- Ownership
- Direct
- Footnotes
- F1
BSX
transaction
Common Stock
Options Exercise
- Transaction value
- $29,386
- Shares
- +1,197
- Change %
- +3.4%
- Price
- $24.55
- Shares after
- 36,291
- Date
- 02 Dec 2024
- Ownership
- Direct
- Footnotes
- F1
BSX
transaction
Common Stock
Sale
- Transaction value
- $633,917
- Shares
- -6,983
- Change %
- -19%
- Price
- $90.78
- Shares after
- 29,308
- Date
- 02 Dec 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BSX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,066
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 02 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,066
- Exercise price
- $17.26
- Footnotes
- F1, F2
BSX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -1,197
- Change %
- -8.3%
- Price
- $0.000000
- Shares after
- 13,183
- Date
- 02 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,197
- Exercise price
- $24.55
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.
Footnote F2
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
Footnote F3
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.